These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17270662)

  • 21. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.
    Adegbola T; Connolly CE; Mortimer G
    J Clin Pathol; 2005 Jul; 58(7):775-8. PubMed ID: 15976350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuroendocrine tumors of the prostate].
    Bours AF; Jorion JL; Donnay M; Ledent G; Van Ruyssevelt C
    Acta Urol Belg; 1993 Sep; 61(3):13-6. PubMed ID: 8256680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review.
    Ferlito A; Rinaldo A
    Head Neck; 2008 Apr; 30(4):518-24. PubMed ID: 18302254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic markers in prostate cancer.
    Ross JS; Sheehan CE; Fisher HA; Kauffman RA; Dolen EM; Kallakury BV
    Expert Rev Mol Diagn; 2002 Mar; 2(2):129-42. PubMed ID: 11962333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare and unusual histological variants of prostatic carcinoma: clinical significance.
    Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Kirkali Z; Montironi R
    BJU Int; 2008 Nov; 102(10):1369-74. PubMed ID: 18793296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
    May M; Siegsmund M; Hammermann F; Loy V; Gunia S
    Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives.
    Helpap B; Köllermann J; Oehler U
    Urol Int; 1999; 62(3):133-8. PubMed ID: 10529661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Small cell carcinoma of the prostate: a case report].
    Yamamoto N; Kinoshita H; Inoue T; Kawakita S; Oguchi N; Muguruma K; Kawa G; Sakaguchi Y; Adachi Y; Sakaida N; Uemura Y; Matsuda T
    Hinyokika Kiyo; 2007 Sep; 53(9):665-9. PubMed ID: 17933147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small cell carcinoma of the breast.
    Mirza IA; Shahab N
    Semin Oncol; 2007 Feb; 34(1):64-6. PubMed ID: 17270668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J; Epstein JI
    Am J Surg Pathol; 2009 Apr; 33(4):583-90. PubMed ID: 19033862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship of neuroendocrine differentiation to biological behavior of prostate cancer].
    Wu XL; Huang KT; Chen W; Chen L; Dong L; Yu ZX
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):472-5. PubMed ID: 19567097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrapulmonary small cell carcinoma of the bladder.
    Shahab N
    Semin Oncol; 2007 Feb; 34(1):15-21. PubMed ID: 17270661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine differentiation in prostate cancer: a sheep in wolf's clothing?
    Slovin SF
    Nat Clin Pract Urol; 2006 Mar; 3(3):138-44. PubMed ID: 16528286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pure primary neuroendocrine tumor of the prostate: a rare entity.
    Ketata S; Ketata H; Fakhfakh H; Sahnoun A; Bahloul A; Boudawara T; Mhiri MN
    Clin Genitourin Cancer; 2006 Jun; 5(1):82-4. PubMed ID: 16859584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts.
    Agemy L; Harmelin A; Waks T; Leibovitch I; Rabin T; Pfeffer MR; Eshhar Z
    Prostate; 2008 Apr; 68(5):530-9. PubMed ID: 18247403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.